These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 1793522)

  • 21. Cardiac glycosides in the treatment of experimental overdose with calcium-blocking agents.
    Ramo MP; Grupp I; Pesola MK; Heikkila J; Luomanmaki K; Schroder T; Grupp G
    Res Exp Med (Berl); 1992; 192(5):335-43. PubMed ID: 1439198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of nifedipine alone and with diltiazem or verapamil in hypertension.
    Saseen JJ; Carter BL; Brown TE; Elliott WJ; Black HR
    Hypertension; 1996 Jul; 28(1):109-14. PubMed ID: 8675249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The application of 4-aminopyridine in calcium channel inhibitors acute poisoning].
    Fiszer M; Kołaciński Z; Rechciński T
    Przegl Lek; 2007; 64(4-5):293-7. PubMed ID: 17724889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies.
    Kawai C; Konishi T; Matsuyama E; Okazaki H
    Circulation; 1981 May; 63(5):1035-42. PubMed ID: 7471362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Side effects of calcium channel blockers.
    Russell RP
    Hypertension; 1988 Mar; 11(3 Pt 2):II42-4. PubMed ID: 3280492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Calcium antagonists in the therapy of hypertension].
    Heidland A; Heidbreder E; Hörl WH; Schäfer RM
    Klin Wochenschr; 1983 Jul; 61(13):633-40. PubMed ID: 6350692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies.
    Graudins A; Lee HM; Druda D
    Br J Clin Pharmacol; 2016 Mar; 81(3):453-61. PubMed ID: 26344579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium channel blockers: spectrum of side effects and drug interactions.
    Hedner T
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():119-30. PubMed ID: 2872768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium antagonists. Pharmacodynamic effects and mechanism of action.
    Zsotér TT; Church JG
    Drugs; 1983 Feb; 25(2):93-112. PubMed ID: 6131809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of halothane and calcium entry blockers on atrioventricular conduction-a comparative study of verapamil, diltiazem, and nifedipine.
    Yokota S; Harada K; Takigawa C; Nakamura I; Kemmotsu O
    J Anesth; 1988 Sep; 2(2):219-26. PubMed ID: 15236084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium channel antagonists, Part I: Fundamental properties: mechanisms, classification, sites of action.
    Opie LH
    Cardiovasc Drugs Ther; 1987 Dec; 1(4):411-30. PubMed ID: 2856470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
    Polster P; Christophe B; Van Damme M; Houlliche A; Chatelain P
    J Pharmacol Exp Ther; 1990 Nov; 255(2):593-9. PubMed ID: 1700816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of calcium antagonists in patients with renal failure.
    Rahn KH; van Bortel LM; Mooy JM
    J Hypertens Suppl; 1987 Dec; 5(4):S67-9. PubMed ID: 3481636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade.
    Noll G; Lüscher TF
    Cardiology; 1998; 89 Suppl 1():10-5. PubMed ID: 9570424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of benidipine hydrochloride on atrioventricular conduction time and postural reflex in gallamine-immobilized cats.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1698-701. PubMed ID: 3219143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracorporeal albumin dialysis in three cases of acute calcium channel blocker poisoning with life-threatening refractory cardiogenic shock.
    Pichon N; Dugard A; Clavel M; Amiel JB; François B; Vignon P
    Ann Emerg Med; 2012 Jun; 59(6):540-4. PubMed ID: 21862178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative cardiovascular effects of verapamil, nifedipine, and diltiazem during halothane anesthesia in swine.
    Kates RA; Zaggy AP; Norfleet EA; Heath KR
    Anesthesiology; 1984 Jul; 61(1):10-8. PubMed ID: 6742468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium channel blocking drug overdose: an Australian series.
    Howarth DM; Dawson AH; Smith AJ; Buckley N; Whyte IM
    Hum Exp Toxicol; 1994 Mar; 13(3):161-6. PubMed ID: 7909677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.